| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/01/2003 | WO2001079291A3 Secreted proteins |
| 05/01/2003 | US20030083318 Therapy for neurodegenerative diseases |
| 05/01/2003 | US20030083256 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 05/01/2003 | US20030082740 Antitumor agent for use in the treatment of cancer |
| 05/01/2003 | US20030082548 Brain selective transmembrane receptor gene |
| 05/01/2003 | US20030082187 Combined cancer treatment methods using antibodies to aminophospholipids |
| 05/01/2003 | US20030082148 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo |
| 05/01/2003 | US20030082106 Improved binding of an amino acid targeting group within the molecules to proteins following specific cleavage of the agent by a peptidase |
| 05/01/2003 | US20030082105 Selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions |
| 05/01/2003 | US20030082103 Targeted therapeutic lipid constructs having cell surface targets |
| 05/01/2003 | CA2464284A1 Magnetic nanodispersion comprising cyclodextrines and method for the production thereof |
| 05/01/2003 | CA2464261A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
| 05/01/2003 | CA2463910A1 Optical pumping modules, polarized gas blending and dispensing systems, and automated polarized gas distribution systems and related devices and methods |
| 04/30/2003 | CN1413736A Multi-hole granular type vascular suppasitory |
| 04/30/2003 | CN1106859C Improvement in or relating to contrast agent |
| 04/29/2003 | US6555104 Administering biocompatible polymer |
| 04/25/2003 | CA2409910A1 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| 04/24/2003 | WO2003034068A1 Localization of disorders associated with kallikreins |
| 04/24/2003 | WO2003033709A2 Regulation of human serine/threonine protein kinase |
| 04/24/2003 | WO2003033680A2 Kinases and phosphatases |
| 04/24/2003 | WO2003033670A2 Method for preparation of single chain antibodies |
| 04/24/2003 | WO2003033654A2 Direct targeting binding proteins |
| 04/24/2003 | WO2003033648A2 Imaging the activity of extracellular proteases in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases |
| 04/24/2003 | WO2003033533A1 Microfluidized leishmania antigen and methods of making and using thereof |
| 04/24/2003 | WO2003033479A1 Enhanced substrate imaging by reversible binding to a paramagnetic complex |
| 04/24/2003 | WO2003033030A1 Pacap compositions and methods for tumor imaging and therapy |
| 04/24/2003 | WO2003032902A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 04/24/2003 | WO2003032901A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 04/24/2003 | WO2003032900A2 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| 04/24/2003 | WO2003032866A2 Detection and treatment of intravascular lesions |
| 04/24/2003 | WO2003032728A2 Methods for preventing or reversing asthma and compositions useful therefor |
| 04/24/2003 | WO2002076509A3 Preparation for the prophylaxis of restenosis |
| 04/24/2003 | WO2001075440A3 Schizophrenia related genes |
| 04/24/2003 | US20030079241 Isolation of precancerous tissue; obtain mammary gland tissue from cancer prone rodent, implant cells into nontrangenic rodent, detect propagation of cells, generate clonal series from propagating cells |
| 04/24/2003 | US20030079235 Assay for measuring enzyme activity in vivo |
| 04/24/2003 | US20030078517 In vivo delivery methods and compositions |
| 04/24/2003 | US20030078493 Magnetic fluid detection method and magnetic fluid detection apparatus |
| 04/24/2003 | US20030078492 Magnetic resonance imaging devices with a contrast medium for improved imaging |
| 04/24/2003 | US20030077675 Diagnosing gastrointestinal tumors in humans; obtain gastric tissue sample, incubate with preferential monoclonal antibody, detect reactivity, reactivity indicates gastrointestinal disorders |
| 04/24/2003 | US20030077568 Screening drugs; obtain cell with preferential phenotypic profile, incubate with drug, monitor effect on cells |
| 04/24/2003 | US20030077305 Administering to a mammal a formualtion comprising cationic lipids/DNA complex, allowing the complex to associate with angiogenic endothelial cells of an angiogenic blood vessel for a time such that the complex enters the target cells |
| 04/24/2003 | US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells |
| 04/24/2003 | US20030077252 Vaccination against plaque forming diseases; inhibiting aggregation of amyloid in mammal and/or to cause disaggregation of amyloid; treating brain disorder, Alzheimer's disease |
| 04/24/2003 | US20030077224 Remote NMR/MRI detection of laser polarized gases |
| 04/24/2003 | CA2463994A1 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| 04/24/2003 | CA2463911A1 Tumor targeted photodiagnostic-phototherapeutic agents |
| 04/24/2003 | CA2463906A1 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 04/24/2003 | CA2463672A1 Direct targeting binding proteins |
| 04/24/2003 | CA2463581A1 Microfluidized leishmania antigen and methods of making and using thereof |
| 04/24/2003 | CA2463017A1 Method for preparation of single chain antibodies |
| 04/24/2003 | CA2462785A1 Kinases and phosphatases |
| 04/24/2003 | CA2461836A1 Detection and treatment of intravascular lesions |
| 04/23/2003 | EP1304124A1 Diagnostic agent for diabetes comprising 13C labelled compound |
| 04/23/2003 | EP1303313A2 Meted hyperpolarized noble gas dispensing methods and associated devices |
| 04/23/2003 | EP1051602B1 Process to solidify and thaw a polarized gas comprising xenon |
| 04/23/2003 | EP1045851B1 Substituted porphyrins |
| 04/23/2003 | EP1007100B1 Improvements in or relating to contrast agents in ultrasound imaging |
| 04/23/2003 | EP0988062A4 Selectively binding ultrasound contrast agents |
| 04/23/2003 | EP0906571B1 Labelling and selection of molecules |
| 04/23/2003 | EP0904264B1 Compositions for increasing the mri contrast in visualising the digestive tract of patients |
| 04/23/2003 | EP0881915B1 Improvements in or relating to contrast agents |
| 04/23/2003 | EP0796111B1 In-vivo diagnostic process by near infrared radiation using cyanine dyes |
| 04/23/2003 | CN1413119A Use of contrast agents in manufacture of diagnostic agent for visualisation of intestinal lumen |
| 04/23/2003 | CN1106214C Method and equipment for preparing air-containing vesicles |
| 04/22/2003 | US6553249 Diagnostic method and diagnostic means used in delivering a medicament to a patient |
| 04/22/2003 | US6551822 NL4 tie ligand homologue |
| 04/22/2003 | US6551594 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
| 04/22/2003 | US6551576 Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 04/22/2003 | US6551575 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity |
| 04/22/2003 | US6551559 Sol-gel coated polarization vessels |
| 04/22/2003 | CA2253951C .delta.1,2bicyclo[4,4,0] functional dyes for contrast enhancement in optical imaging |
| 04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
| 04/17/2003 | WO2003031452A2 4-haloethenylphenyl tropane:serotonin transporter imaging agents |
| 04/17/2003 | WO2003030951A2 Sampling article for determining quantitative and qualitative drug transfer to skin |
| 04/17/2003 | WO2003030947A2 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 04/17/2003 | WO2003030938A1 Immunotherapeutics for cancer |
| 04/17/2003 | WO2003030879A1 Particle immobilized coatings and uses thereof |
| 04/17/2003 | WO2003030636A1 Rodent with urinary disturbance and method of constructing the same, and method of screening remedy for urinary disturbance using the rodent |
| 04/17/2003 | WO2003002156A3 Contrast agents comprising metal particles encapsulated in microspheres for use in medical diagnostic imaging and therapy |
| 04/17/2003 | WO2002072636A3 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 04/17/2003 | WO2002021134A3 Methods of diagnosing breast cancer and screening for modulators |
| 04/17/2003 | WO2002018576A3 Compositions and methods relating to lung specific genes |
| 04/17/2003 | US20030073878 Radioactive seed with multiple markers and method for using same |
| 04/17/2003 | US20030073715 Nasal administering; side effect reduction |
| 04/17/2003 | US20030073642 Methods and formulations for delivery of pharmacologically active agents |
| 04/17/2003 | US20030072763 Absorb in the low- energy, ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum that are used for the phototherapy of tumors and other lesions |
| 04/17/2003 | US20030072714 Microfluidized leishmania lysate and methods of making and using thereof |
| 04/17/2003 | US20030072713 Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses |
| 04/17/2003 | US20030072711 Eye treatment |
| 04/17/2003 | DE10135356C1 Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen Macrocyclic metal complexes and their use for the preparation of conjugates with biomolecules |
| 04/17/2003 | DE10135355C1 Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie Conjugates of macrocyclic metal complexes with biomolecules and their use for the preparation of agents for NMR and Radiology and Radiotherapy |
| 04/17/2003 | CA2459727A1 4-haloethenylphenyl tropane: serotonin transporter imaging agents |
| 04/17/2003 | CA2458645A1 Intracellular signaling molecules |
| 04/16/2003 | EP1302465A1 Enhanced substrate imaging by reversible binding to a paramagnetic complex |
| 04/16/2003 | EP1301605A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 04/16/2003 | EP1301595A2 G-protein coupled receptors |
| 04/16/2003 | EP1301463A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 04/16/2003 | EP1301213A2 Multi-component biological transport systems |
| 04/16/2003 | EP1301183A1 Functionalized active-nucleus complex sensor |
| 04/16/2003 | EP1301164A1 Improved diagnostic method for detecting dysplastic epithelial tissue |